Recent Updates
Recently added Catalysts
MDXG Positive Sentiment

MIMEDX to Host Second Quarter 2025 Operating and Financial Results Conference Call on July 30

Key Takeaway: MiMedx Group, Inc. announced that it will report its operating and financial results for the second quarter of 2025 on July 30, after market close. The senior management team will conduct a conference call to discuss the results, scheduled for 4:30 p.m. ET the same day. The event indicates the company's continuous engagement in financial transparency and performance update for investors.
Price reaction · baseline $6.33 (2025-07-15 close) · hit after-hours · clean, no other MDXG news in the window
day 0 close
+6%
day 1 · peak
+6.2%
day 3
+5.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • MIMEDX is reporting its second quarter results, indicating ongoing operations.
  • The company continues to focus on innovation in wound care solutions.
  • MIMEDX has a decade of experience in helping clinicians manage chronic wounds.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~40 mo
Low dilution risk
Lead asset
Micronized DHACM
Phase 3 · Tendonitis;Achilles

Full Press Release Details

MARIETTA, Ga., July 16, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the second quarter ended June 30, 2025 after the market close on Wednesday, July 30, 2025. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 4:30 p.m. Eastern Time on the same day.
The conference call can be accessed using the following information:
U.S. Investors: 877-407-6184
International Investors: 201-389-0877
Conference ID: 13754722
A replay of the webcast will be available for approximately 30 days on the Company’s website at www.mimedx.com following the conclusion of the event.
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.

Frequently Asked Questions

When will MiMedx report its Q2 financial results for 2025?

MiMedx will report its Q2 financial results on July 30, 2025.

What time is the MiMedx conference call on July 30, 2025?

The conference call will start at 4:30 p.m. Eastern Time.

How can I access the MiMedx conference call?

U.S. investors can call 877-407-6184; international investors can call 201-389-0877.

Is there a replay available for the MiMedx call?

Yes, a replay will be available for about 30 days on their website.

What is MiMedx's main focus in healthcare?

MiMedx focuses on providing solutions for chronic and hard-to-heal wounds.

Last updated: Jul 16, 2025